Cefmetazole (CS-1170), a “new” cephamycin with a decade of clinical experience
- 31 October 1989
- journal article
- review article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 12 (5) , 367-379
- https://doi.org/10.1016/0732-8893(89)90106-5
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Spontaneous Reports of Bleeding: Comparison of N-Methylthiotetrazole Side Chain (MTT) and Non-MTT CephalosporinsThe Journal of Infectious Diseases, 1988
- Criteria for in vitro susceptibility testing of cefotetan: Correlations with clinical and bacteriologic responsesThe American Journal of Surgery, 1988
- Cefotetan: A review of the microbiologic properties and antimicrobial spectrumThe American Journal of Surgery, 1988
- In vitro susceptibility of the Bacteroides fragilis group in community hospitalsDiagnostic Microbiology and Infectious Disease, 1986
- Effects of various cephem antibiotics on ethanol metabolism and their structure-activity relationsJournal of Pharmacy and Pharmacology, 1986
- In-vitro and in-vivo activities of a novel cephamycin MT-141 against the Bacteroides fragilis group in comparison with six cephem antibioticsJournal of Antimicrobial Chemotherapy, 1985
- In-vitro andin-vivo activities of antimicrobial agents againstAcinetobacter calcoaceticusJournal of Antimicrobial Chemotherapy, 1985
- Cefmetazole (CS-1170): a new cephamycin with activity against Gram-negative bacilli and staphylococciJournal of Antimicrobial Chemotherapy, 1982
- Investigation of the β-lactamase stability of ceftazidime and eight other new cephalosporin antibioticsJournal of Antimicrobial Chemotherapy, 1982
- Bactericidal Activity of Cefazolin, Cefoxitin, and Cefmetazole against Escherichia coli and Klebsiella pneumoniaeChemotherapy, 1982